Moderate to Very Severe COPD
1 clinical trials · Condition
◉ Watch Moderate to Very Severe COPD
| Record | Firm | Date |
|---|---|---|
| Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. (NCT01966107) | AstraZeneca | 2013-10-16 |
Track Moderate to Very Severe COPD automatically
Every clearance here is in the API, with alerts when new ones post.